Stay updated on Avelumab in Combination with CRT Clinical Trial

Sign up to get notified when there's something new on the Avelumab in Combination with CRT Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Avelumab in Combination with CRT Clinical Trial page

  1. Check
    today
    No Change Detected
  2. Check
    yesterday
    No Change Detected
  3. Check
    2 days ago
    Change Detected
    Summary
    The value of Revision has been updated from v2.8.0 to v2.8.1, indicating a recent revision in the content of the webpage.
    Difference
    0.0%
    Check dated 2024-06-13T21:47:58.000Z thumbnail image
  4. Check
    3 days ago
    No Change Detected
  5. Check
    5 days ago
    No Change Detected
  6. Check
    10 days ago
    Change Detected
    Summary
    The value 7 has recently changed to 8 on the webpage. This change represents an update in the study record details of a phase 3 randomized, placebo-controlled study evaluating the safety and anti-tumor activity of Avelumab in combination with standard of care chemoradiation versus standard of care chemoradiation alone in the front-line treatment of patients with locally advanced head and neck cancer.
    Difference
    0.0%
    Check dated 2024-06-06T14:18:28.000Z thumbnail image
  7. Check
    25 days ago
    Change Detected
    Summary
    The 'Participation Criteria' section has been updated to include detailed eligibility criteria for study participants, specifying inclusion and exclusion criteria for individuals with squamous cell carcinoma of the head and neck.
    Difference
    10%
    Check dated 2024-05-22T20:32:41.000Z thumbnail image
  8. Check
    46 days ago
    Change Detected
    Difference
    0.4%
    Check dated 2024-04-30T22:40:15.000Z thumbnail image

Stay in the know with updates to Avelumab in Combination with CRT Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Avelumab in Combination with CRT Clinical Trial page.